Sign In
Get Clay Free →

Suggestions

    Matthijs Scheltema

    Urology Registrar (AIOS) bij Amsterdam UMC

    Matthijs J.V. Scheltema is a medical doctor and PhD candidate in the Department of Urology at the AMC University Hospital in Amsterdam, Netherlands.1 He completed his medical degree with distinction at the University of Amsterdam.1 His clinical work focuses on prostate cancer, utilizing advanced imaging techniques such as mpMRI, TRUS/MRI fusion, MR-guided biopsies, and Contrast-Enhanced Ultrasound imaging.1

    Scheltema's research primarily revolves around Focal Therapy in prostate cancer, particularly using Irreversible Electroporation (IRE).12 He is the coordinating researcher for an international multicenter randomized controlled trial comparing focal vs extended ablation in localized prostate cancer using IRE.1 Additionally, he collaborates with the Biomedical Engineering Department at AMC to develop new focal prostatic imaging modalities for prostate cancer detection.1

    His work has been published in various medical journals, including articles on IRE for prostate cancer treatment and robot-assisted prostate-specific membrane antigen-radioguided surgery.23 Scheltema has also been involved in numerical simulation modeling of IRE treatment for prostate cancer.4

    As of 2018, Scheltema was presenting on Focal IRE at urology conferences, indicating his ongoing expertise in this area.5 His research continues to contribute to the field of urology, particularly in the areas of prostate cancer diagnosis and treatment.

    Highlights

    Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided ...
    Numerical simulation modeling of the irreversible electroporation ...
    Impact on genitourinary function and quality of life following focal ...

    Related Questions

    What are Matthijs Scheltema's main research interests in urology?
    How does Matthijs Scheltema contribute to the development of new imaging modalities for prostate cancer?
    What is the significance of Matthijs Scheltema's work on focal therapy in prostate cancer?
    How does Matthijs Scheltema's research on irreversible electroporation (IRE) impact prostate cancer treatment?
    What are the key findings from Matthijs Scheltema's multicenter randomized controlled trial on focal vs extended ablation in prostate cancer?
    M
    Add to my network

    Location

    Amsterdam, North Holland, Netherlands